Thus, our qualitative and quantitative data revealed that the DDM system is specifically and selectively bound to the overexpressed FR- and CD44 receptors in cancer cells via CD44/FR- receptor-mediated endocytosis and the responsive release under acidic conditions. Here, CD44 is linked to cancer.